Swiss National Bank Purchases 3,400 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Swiss National Bank increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 0.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,052,800 shares of the medical equipment provider's stock after buying an additional 3,400 shares during the period. Swiss National Bank owned 0.30% of Intuitive Surgical worth $517,209,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. M&G Plc bought a new position in Intuitive Surgical in the first quarter valued at about $1,318,000. TIAA Trust National Association raised its stake in shares of Intuitive Surgical by 26.6% during the first quarter. TIAA Trust National Association now owns 2,729 shares of the medical equipment provider's stock worth $1,089,000 after buying an additional 573 shares during the last quarter. Penobscot Investment Management Company Inc. lifted its holdings in Intuitive Surgical by 3.2% in the first quarter. Penobscot Investment Management Company Inc. now owns 2,430 shares of the medical equipment provider's stock valued at $970,000 after buying an additional 75 shares during the period. Rockport Wealth LLC bought a new position in Intuitive Surgical in the first quarter valued at approximately $22,895,000. Finally, O Shaughnessy Asset Management LLC grew its holdings in Intuitive Surgical by 20.5% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 29,231 shares of the medical equipment provider's stock worth $11,666,000 after acquiring an additional 4,973 shares during the period. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $10.19 during trading on Friday, hitting $527.61. The stock had a trading volume of 1,447,901 shares, compared to its average volume of 1,417,223. Intuitive Surgical, Inc. has a 12 month low of $295.02 and a 12 month high of $544.38. The company's 50-day moving average price is $499.29 and its two-hundred day moving average price is $458.50. The company has a market capitalization of $187.92 billion, a PE ratio of 84.82, a P/E/G ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the company's stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total value of $19,591,902.12. Following the sale, the senior vice president now owns 3,001 shares in the company, valued at $1,461,006.84. This represents a 93.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Jamie Samath sold 22,903 shares of Intuitive Surgical stock in a transaction that occurred on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the transaction, the insider now owns 8,757 shares of the company's stock, valued at $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 91,178 shares of company stock worth $45,897,071. Corporate insiders own 0.90% of the company's stock.

Analysts Set New Price Targets

ISRG has been the subject of a number of analyst reports. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a "buy" rating in a research note on Friday, October 18th. Redburn Atlantic upgraded Intuitive Surgical from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Piper Sandler reaffirmed an "overweight" rating and issued a $538.00 price target (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Mizuho lifted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an "outperform" rating in a research note on Thursday, October 17th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and an average price target of $513.74.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.